Protalix BioTherapeutics, Inc. (PLX)

Typically moves ±9.09% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-14 ESTIMATED

Protalix BioTherapeutics, Inc. (PLX) has reported earnings 21 times since May 14, 2021. The stock moves an average of ±9.09% the day after reporting, closing higher 47.6% of the time. Its largest post-earnings gain was +14.46% (Aug 07, 2023) and its largest decline was -40.48% (May 09, 2025). The next earnings report is predicted for 2026-08-14 (estimated).

Earnings reactions

How PLX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±9.09%

Positive %

47.6%

Negative %

52.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 13, 2026	☀ PRE	+2.37%	open_in_new
Mar 18, 2026	☀ PRE	-20.79%	open_in_new
Nov 13, 2025	☀ PRE	-9.81%	open_in_new
Aug 14, 2025	☀ PRE	-5.59%	open_in_new
May 09, 2025	☀ PRE	-40.48%	open_in_new
Mar 17, 2025	☀ PRE	+9.37%	open_in_new
Nov 14, 2024	☀ PRE	+13.71%	open_in_new
Aug 14, 2024	☀ PRE	-10.58%	open_in_new
May 10, 2024	☀ PRE	-12%	open_in_new
Mar 14, 2024	☀ PRE	-9.87%	open_in_new
Nov 06, 2023	☀ PRE	-18.38%	open_in_new
Aug 07, 2023	☀ PRE	+14.46%	open_in_new
May 18, 2023	☀ PRE	-9.32%	open_in_new
Feb 27, 2023	☀ PRE	+2.75%	open_in_new
Nov 14, 2022	☀ PRE	+1.9%	open_in_new
Aug 15, 2022	☀ PRE	+0.81%	open_in_new
May 16, 2022	☀ PRE	+0.94%	open_in_new
Mar 31, 2022	☀ PRE	+0.95%	open_in_new
Nov 15, 2021	☀ PRE	+0.88%	open_in_new
Aug 16, 2021	☀ PRE	-1.49%	open_in_new
May 14, 2021	☀ PRE	-4.53%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±9.09%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 14 →

Funds holding

$13879753

Total value held

Buying

9 added · 4 reduced

Blackrock, Inc.

$7848807 -0.83%

State Street Corp

$2111009 +66.22%

Northern Trust Corp

$1921422 +2.28%

Morgan Stanley

$654890 +128.65%

Goldman Sachs Group Inc

$545418 -4.36%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260625	open_in_new SEC.gov
8-K	20260521	open_in_new SEC.gov
10-Q	20260513	open_in_new SEC.gov
8-K	20260513	open_in_new SEC.gov
ARS	20260430	open_in_new SEC.gov
DEF 14A	20260430	open_in_new SEC.gov
3/A	20260427	open_in_new SEC.gov
3/A	20260427	open_in_new SEC.gov
SCHEDULE 13G/A	20260330	open_in_new SEC.gov
10-K	20260318	open_in_new SEC.gov

Frequently asked about PLX earnings

When does Protalix BioTherapeutics, Inc. report earnings next? expand_more

Protalix BioTherapeutics, Inc. (PLX)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PLX stock move after earnings? expand_more

Over 21 reports, PLX has moved an average of ±9.09% the session after earnings, closing higher 47.6% of the time.

What was PLX's biggest post-earnings move? expand_more

PLX's largest post-earnings gain on record was +14.46% on Aug 07, 2023, and its largest decline was -40.48% on May 09, 2025.

Where can I find Protalix BioTherapeutics, Inc.'s SEC filings? expand_more

All of Protalix BioTherapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.